Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging

Cancer Letters

Volumn 263, Issue 1, 2008, Pages 99-106

  Tang, Bixia ^a   Yang, Zhi ^b   Huang, Jie ^a   Hao, Zhiyong ^a   Li, Wenjing ^a   Cui, Lianxian ^a   He, Wei ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Antibody; Diagnosis; Imaging; MICA; Ovarian epithelial carcinoma; Technetium

Indexed keywords

COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 10C6; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ISOTOPE LABELING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; FEASIBILITY STUDIES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; ORGANOTECHNETIUM COMPOUNDS; OVARIAN NEOPLASMS; TISSUE DISTRIBUTION;

MUS;

EID: 41149131646     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.027     Document Type: Article

References (23)

1. Tiffen J., and Mahon S.M. Ovarian cancer screening: are there any options?. Clin. J. Oncol. Nurs. 9 (2005) 369-372
2. Bahram S., Bresnahan M., Geraghty D.E., and Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 91 (1994) 6259-6263
3. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., and Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93 (1996) 12445-12450
4. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., and Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96 (1999) 6879-6884
5. Yamamoto K., Fujiyama Y., Andoh A., Bamba T., and Okabe H. Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2). Biochim. Biophys. Acta 1526 (2001) 10-12
6. Gong W., Fan L., Yang J., Xu L., and Yao F. Analysis on polymorphism in exons 2, 3 and 4 of the MICA gene in three different Chinese populations. Chin. J. Med. Genet. 19 (2002) 336-339
7. Qi J., Zhang J., Zhang S., Cui L., and He W. Immobilized MICA could expand human Vdelta1 gamma delta T cells in vitro that displayed major histocompatibility complex class I chain-related A-dependent cytotoxicity to human epithelial carcinomas. Scand. J. Immunol. 58 (2003) 211-220
8. Karube Y., Katsuno K., and Takata J. Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor. Nucl. Med. Biol. 23 (1996) 753-759
9. Lindmo T., Boven E., Cuttitta F., Fedorko J., and Bunn Jr. P.A. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods 72 (1984) 77-89
10. Yang D.J., Kim E.E., and Inoue T. Targeted molecular imaging in oncology. Ann. Nucl. Med. 20 (2006) 1-11
11. Holdenrieder S., Stieber P., Peterfi A., Nagel D., Steinle A., and Salih H.R. Soluble MICA in malignant diseases. Int. J. Cancer 118 (2006) 684-687
12. Otto C., Jensen M., Dietlein M., Fischer T., Schmidt M., Tawadros S., et al. Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID mice. Nucl. Med. Commun. 27 (2006) 171-178
13. Behr T., Becker W., Hannappel E., Goldenberg D.M., and Wolf F. Targeting of liver metastases of colorectal cancer with IgG, F(ab′)2, and Fab′ anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics. Cancer Res. 55 Suppl 23 (1995) 5777s-5785s
14. Carrel F., Amstutz H., Novak-Hofer I., and Schubiger P.A. Evaluation of radioiodinated and radiocopper labeled monovalent fragments of monoclonal antibody chCE7 for targeting of neuroblastoma. Nucl. Med. Biol. 24 (1997) 539-546
15. Willuda J., Kubetzko S., Waibel R., Schubiger P.A., Zangemeister-Wittke U., and Pluckthun A. Tumor targeting of mono-, di-, and tetravalent anti-p185 (HER-2) mini antibodies multimerized by self-associating peptides. J. Biol. Chem. 276 (2001) 14385-14392
16. Groh V., Wu J., Yee C., and Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419 (2002) 734-738
17. Salih H.R., Antropius H., Gieseke F., Lutz S.Z., Kanz L., Rammensee H.G., et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102 (2003) 1389-1396
18. Olafsen T., Kenanova V.E., Sundaresan G., Anderson A.L., Crow D., Yazaki P.J., et al. Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging. Cancer Res. 65 (2005) 5907-5916
19. Watanabe Y., Maruoka T., Walter L., and Kasahara M. Comparative genomics of the Mill family: a rapidly evolving MHC class I gene family. Eur. J. Immunol. 34 (2004) 1597-1607
20. Kasahara M., Watanabe Y., Sumasu M., and Nagata T. A family of MHC class I-like genes located in the vicinity of the mouse leukocyte receptor complex. Proc. Natl. Acad. Sci. USA 99 (2002) 13687-13692
21. Watson N.F., Spendlove I., Madjd Z., McGilvray R., Green A.R., Ellis I.Q., et al. Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. Int. J. Cancer 118 (2006) 1445-1452
22. Holdenrieder S., Stieber P., Peterfi A., Nagel D., Steinle A., and Salih H.R. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA. Cancer Immunol. Immunother. 55 (2006) 1584-1589
23. Carbone E., Neri P., Mesuraca M., Fulciniti M.T., Otsuki T., Pende D., et al. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 105 (2005) 251-258